Cardiac arrest and COVID-19: inflammation, angiotensin-converting enzyme 2, and the destabilization of non-significant coronary artery disease-a case report.
Sebastien ColombierThabodhan MahendiranLars NiclaussMatthias KirschPublished in: European heart journal. Case reports (2020)
Myocardial injury is frequently seen among critically unwell COVID-19 patients and increases the risk of mortality. This case illustrates several potential mechanisms that are thought to drive the cardiac complications seen in COVID-19. We present the potential role of inflammation and ACE2 in the pathophysiology of COVID-19.
Keyphrases
- sars cov
- coronavirus disease
- angiotensin converting enzyme
- cardiac arrest
- angiotensin ii
- coronary artery disease
- oxidative stress
- respiratory syndrome coronavirus
- cardiovascular events
- risk factors
- percutaneous coronary intervention
- heart failure
- type diabetes
- risk assessment
- atrial fibrillation
- transcatheter aortic valve replacement
- aortic valve